Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell of artery | 9 studies | 50% ± 26% | |
endothelial cell | 7 studies | 30% ± 14% | |
capillary endothelial cell | 6 studies | 58% ± 26% | |
vein endothelial cell | 4 studies | 30% ± 19% | |
fibroblast | 3 studies | 19% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 22% ± 6% |
Insufficient scRNA-seq data for expression of TMEM100 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 60% | 361.19 | 1585 / 2642 | 98% | 103.13 | 694 / 705 |
thymus | 90% | 628.91 | 586 / 653 | 64% | 14.38 | 388 / 605 |
ovary | 98% | 2104.89 | 176 / 180 | 53% | 18.76 | 228 / 430 |
lung | 100% | 16082.59 | 577 / 578 | 43% | 6.24 | 498 / 1155 |
prostate | 87% | 799.84 | 213 / 245 | 51% | 4.38 | 258 / 502 |
breast | 99% | 2303.69 | 455 / 459 | 25% | 2.56 | 275 / 1118 |
stomach | 93% | 2269.08 | 334 / 359 | 16% | 1.74 | 45 / 286 |
intestine | 99% | 1155.00 | 953 / 966 | 9% | 0.82 | 45 / 527 |
bladder | 95% | 887.67 | 20 / 21 | 12% | 1.19 | 60 / 504 |
adrenal gland | 22% | 92.77 | 57 / 258 | 84% | 19.38 | 193 / 230 |
adipose | 100% | 2419.74 | 1200 / 1204 | 0% | 0 | 0 / 0 |
esophagus | 87% | 741.43 | 1253 / 1445 | 5% | 0.26 | 10 / 183 |
heart | 88% | 776.11 | 754 / 861 | 0% | 0 | 0 / 0 |
uterus | 59% | 331.08 | 101 / 170 | 19% | 4.37 | 87 / 459 |
spleen | 71% | 530.35 | 172 / 241 | 0% | 0 | 0 / 0 |
skin | 60% | 347.45 | 1089 / 1809 | 10% | 2.61 | 48 / 472 |
liver | 45% | 197.78 | 101 / 226 | 21% | 3.04 | 84 / 406 |
pancreas | 6% | 25.10 | 21 / 328 | 53% | 4.30 | 94 / 178 |
blood vessel | 53% | 331.42 | 704 / 1335 | 0% | 0 | 0 / 0 |
muscle | 50% | 401.71 | 403 / 803 | 0% | 0 | 0 / 0 |
kidney | 10% | 32.27 | 9 / 89 | 34% | 4.47 | 304 / 901 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.74 | 5 / 29 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.23 | 2 / 45 |
peripheral blood | 1% | 1.91 | 5 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001525 | Biological process | angiogenesis |
GO_0003198 | Biological process | epithelial to mesenchymal transition involved in endocardial cushion formation |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0071773 | Biological process | cellular response to BMP stimulus |
GO_0001701 | Biological process | in utero embryonic development |
GO_0045603 | Biological process | positive regulation of endothelial cell differentiation |
GO_0001570 | Biological process | vasculogenesis |
GO_0051930 | Biological process | regulation of sensory perception of pain |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0050848 | Biological process | regulation of calcium-mediated signaling |
GO_0060842 | Biological process | arterial endothelial cell differentiation |
GO_2001214 | Biological process | positive regulation of vasculogenesis |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0005886 | Cellular component | plasma membrane |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0043204 | Cellular component | perikaryon |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005515 | Molecular function | protein binding |
GO_0003674 | Molecular function | molecular_function |
Gene name | TMEM100 |
Protein name | Transmembrane protein 100 |
Synonyms | |
Description | FUNCTION: Plays a role during embryonic arterial endothelium differentiation and vascular morphogenesis through the ACVRL1 receptor-dependent signaling pathway upon stimulation by bone morphogenetic proteins, such as GDF2/BMP9 and BMP10. Involved in the regulation of nociception, acting as a modulator of the interaction between TRPA1 and TRPV1, two molecular sensors and mediators of pain signals in dorsal root ganglia (DRG) neurons. Mechanistically, it weakens their interaction, thereby releasing the inhibition of TRPA1 by TRPV1 and increasing the single-channel open probability of the TRPA1-TRPV1 complex. . |
Accessions | ENST00000575734.5 ENST00000424486.3 Q9NV29 ENST00000571679.1 A0A0A0MTR3 |